Assistant Professor and Myeloma Physician
University of Toronto, Princess Margaret Cancer Centre, Canada
Dr. Guido Lancman, M.D., M.Sc., is an Assistant Professor in the Department of Medicine at the University of Torontto and Myeloma Physician at Princess Margaret Cancer Centre. He is a clinician-investigator with a clinical focus on plasma cell dyscrasis and research interest in optimizing the efficacy and safety of novel therapies in multiple myeloma, with a particular interest in immunotherapies. He is involved in the development of early phase multiple myeloma clinical trials through the Princess Margaret Cancer Centre and through the Canadian Myeloma Research Group, as well as site PI of large multi-centre trials.